These results revealed that increased RANKL levels in the synovium of arthritis patients are associated with molecules that regulate arthritic features, including proinflammatory cytokines, catabolic factors, and processes leading to bone and cartilage destruction. The gene discussed is TNFSF11; the disease is arthritic joint disease.